Volume Alert - PAH 25.15 Platform Specialty Products Corp.

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 11:45 AM

Volume Alert - PAH 25.15 Platform Specialty Products Corp. $PAH Hit a high today of 25.42 Closing the day 10:30 at 25.15 +0.14 +0.56% With a day low of 24.70 and a total volume of 2,877,906.

PAH Recent Posts: http://investorshangout.com/Platform-Specialt...PAH-62519/

PAH Platform Specialty Products Corp. Recent Headline News

Platform Specialty Products Corporation Announces Pricing of a $350 Million Public Offering of Common Stock
GlobeNewswire - Wed Nov 12, 7:00AM CST
Platform Specialty Products Corporation (NYSE

AH) ("Platform"

today announced the pricing of an underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $24.50 per share. The gross proceeds to Platform from this offering are expected to be approximately $350 million, before deducting underwriting discounts and commissions and offering expenses payable by Platform. Platform has granted to the underwriters a 30-day option to purchase an additional 2,145,000 shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform. The offering is expected to close on or about November 17, 2014, subject to customary closing conditions.
PAH: 25.10 (+0.09)

Monitoring Avante Logixx Results: Under Promise, Over Deliver
Unconventional Capital Wisdom - at Seeking Alpha - Tue Nov 11, 10:22AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products expects USD350m from planned public offering
M2 - Tue Nov 11, 6:12AM CST
Specialist chemicals company Platform Specialty Products (NYSE

AH) reported on Monday that it intends to start its USD350m public offering of common shares.
PAH: 25.10 (+0.09)

Platform Specialty Products Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Mon Nov 10, 3:42PM CST
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Platform Specialty Products Corp was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny Technologies,...
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Launch of Public Offering of Common Stock
GlobeNewswire - Mon Nov 10, 6:12AM CST
Platform Specialty Products Corporation (NYSE

AH) ("Platform"

today announced that it has commenced a $350 million underwritten public offering of shares of its common stock. In connection with the offering, Platform intends to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform.
PAH: 25.10 (+0.09)

These Six Stocks Are Driving Bill Ackman's Extraordinary 2014 Run
at The Street - Fri Nov 07, 12:01PM CST
It's been a banner year for billionaire hedge fund magnate Bill Ackman -- especially considering just a handful of companies are propelling his big 2014 run.
AGN: 196.88 (+1.54), VRX: 130.49 (+0.46), HHC: 147.10 (+0.07), PAH: 25.10 (+0.09), CP: 209.33 (-0.68), APD: 134.56 (-0.36), BKW: 31.94 (-0.44)

Paul J. Collins Joins Centerview Partners
PR Newswire - Thu Nov 06, 8:00AM CST
Centerview Partners, a leading independent investment banking and advisory firm, announced today that Paul J. Collins has joined the firm as a partner in New York. Mr. Collins brings over 25 years of investment banking experience with deep expertise in chemicals and will enhance Centerview's capabilities in the sector.
BX: 31.89 (+0.27), EMN: 83.45 (-0.88), MRD: 22.94 (-0.75), PAH: 25.10 (+0.09), PPG: 203.48 (-1.78), DOW: 49.99 (+0.47)

Platform Specialty's (PAH) CEO Dan Leever on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 11:42AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 7:10AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results
GlobeNewswire - Wed Nov 05, 7:00AM CST
- Net sales of $197 million, up 4.4% organically
PAH: 25.10 (+0.09)

Chemtura Completes Sale of Its Agrochemicals Business to Platform Specialty Products Corporation
GlobeNewswire - Mon Nov 03, 5:30PM CST
Chemtura Corporation (NYSE:CHMT) (Euronext Paris:CHMT) ("Chemtura"

today announced that it has completed the sale of its agrochemicals business, Chemtura AgroSolutions, to Platform Specialty Products Corporation (NYSE

AH) ("Platform"

, a global specialty chemicals company, for approximately $1 billion, consisting of $950 million in cash and 2 million shares of Platform's common stock. The purchase price is subject to customary post-closing adjustments.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products Corporation Closes Acquisition of Chemtura AgroSolutions Business and Syndicated $405 Million of Term Loans Facility
GlobeNewswire - Mon Nov 03, 5:27PM CST
- Transaction expected to be immediately accretive to Platform's adjusted earnings, pre-synergies
PAH: 25.10 (+0.09)

Chemtura: A High-Potential Specialty Chemicals Producer
Daniel Lynch - at Seeking Alpha - Fri Oct 24, 3:51PM CDT

ASH: 112.28 (-0.44), GE: 26.43 (+0.05), PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products: The Architect And The Builder
Unconventional Capital Wisdom - at Seeking Alpha - Thu Oct 23, 5:15AM CDT

PAH: 25.10 (+0.09)

Why Platform Specialty Products (PAH) Stock Is Gaining Today
at The Street - Mon Oct 20, 2:17PM CDT
Platform Specialty Products (PAH) shares are climbing after the company announced it was purchasing Arysta LifeScience for $3.5 billion.
PAH: 25.10 (+0.09)

Platform Specialty to buy Arysta for $3.51 billion
AP - Mon Oct 20, 9:35AM CDT
NEW YORK (AP) — Platform Specialty Products Corp. said Monday that it will spend about $3.51 billion to buy rival chemical maker Arysta LifeScience Ltd. to diversify its product offerings.
PAH: 25.10 (+0.09)

Permira Books $3.5 Billion Exit From Ireland-based Arysta LifeScience
at The Street - Mon Oct 20, 9:06AM CDT
Sale to Martin Franklin's chemicals rollup Platform Specialty Products provides the London firm with a 1.7 times return on investment.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform to buy chemicals maker Arysta for $3.51B
Seeking Alpha - at Seeking Alpha - Mon Oct 20, 7:06AM CDT

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Preliminary Third Quarter Financial Results Record Q3 Adjusted EBITDA
GlobeNewswire - Mon Oct 20, 6:15AM CDT
- Net sales expected to be approximately $195 million to $197 million
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Signs Definitive Agreement to Acquire Arysta LifeScience Limited for Approximately $3.51 Billion
GlobeNewswire - Mon Oct 20, 6:14AM CDT
- Acquisition expected to be immediately accretive to Platform's adjusted earnings per share, pre-synergies
PAH: 25.10 (+0.09)

Element Solutions Inc. (ESI) Stock Research Links

ESI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

UNISORB Expands Reach with BILZ Acquisition

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

York Urged to Retire Research Macaques After Probe

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Early Education's Massive Impact: Key Skills for Success

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Backroads Sets 2027 Egypt Tour with Active Adventures

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Texas Institute Leads Trailblazing Arrhythmia Study

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Evotec and Plectonic Join Forces on Tumor Immunotherapy

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...